{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T05:48:00Z","timestamp":1792648080457,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02625-4","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T10:34:54Z","timestamp":1776335694000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["mTOR-driven integrin \u03b24-enriched extracellular vesicles from lenvatinib-resistant hepatocellular carcinoma fuel lung metastasis via fibroblast-niche formation"],"prefix":"10.1038","volume":"11","author":[{"given":"Tiantian","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xufeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoting","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beiyuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1141-0668","authenticated-orcid":false,"given":"Yinghan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chak Lam","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2433-7199","authenticated-orcid":false,"given":"Qiongzhu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lun-Xiu","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"2625_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"2625_CR2","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41571-018-0073-4","volume":"15","author":"JM Llovet","year":"2018","unstructured":"Llovet, J. M., Montal, R., Sia, D. & Finn, R. S. Molecular therapies and precision medicine for hepatocellular carcinoma. Nat. Rev. Clin. Oncol. 15, 599\u2013616 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2625_CR3","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41575-019-0179-x","volume":"16","author":"J Bruix","year":"2019","unstructured":"Bruix, J., da Fonseca, L. G. & Reig, M. Insights into the success and failure of systemic therapy for hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol. 16, 617\u2013630 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2625_CR4","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s40265-019-01116-x","volume":"79","author":"ZT Al-Salama","year":"2019","unstructured":"Al-Salama, Z. T., Syed, Y. Y. & Scott, L. J. Lenvatinib: a review in hepatocellular carcinoma. Drugs 79, 665\u2013674 (2019).","journal-title":"Drugs"},{"key":"2625_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41568-021-00427-0","volume":"22","author":"F Weiss","year":"2022","unstructured":"Weiss, F., Lauffenburger, D. & Friedl, P. Towards targeting of shared mechanisms of cancer metastasis and therapy resistance. Nat. Rev. Cancer 22, 157\u2013173 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"2625_CR6","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/s41568-020-00299-w","volume":"20","author":"A M\u00f6ller","year":"2020","unstructured":"M\u00f6ller, A. & Lobb, R. J. The evolving translational potential of small extracellular vesicles in cancer. Nat. Rev. Cancer 20, 697\u2013709 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"2625_CR7","doi-asserted-by":"crossref","unstructured":"Kalluri, R. & LeBleu, V. S. The biology, function, and biomedical applications of exosomes. Science 367, eaau6977 (2020).","DOI":"10.1126\/science.aau6977"},{"key":"2625_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G van Niel","year":"2018","unstructured":"van Niel, G., D\u2019Angelo, G. & Raposo, G. Shedding light on the cell biology of extracellular vesicles. Nat. Rev. Mol. Cell Biol. 19, 213\u2013228 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2625_CR9","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/s41556-019-0404-4","volume":"21","author":"G Rodrigues","year":"2019","unstructured":"Rodrigues, G. et al. Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis. Nat. Cell Biol. 21, 1403\u20131412 (2019).","journal-title":"Nat. Cell Biol."},{"key":"2625_CR10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41556-018-0256-3","volume":"21","author":"I Keklikoglou","year":"2019","unstructured":"Keklikoglou, I. et al. Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models. Nat. Cell Biol. 21, 190\u2013202 (2019).","journal-title":"Nat. Cell Biol."},{"key":"2625_CR11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ccell.2016.06.021","volume":"30","author":"Y Liu","year":"2016","unstructured":"Liu, Y. et al. Tumor exosomal RNAs promote lung pre-metastatic niche formation by activating alveolar epithelial TLR3 to recruit neutrophils. Cancer Cell 30, 243\u2013256 (2016).","journal-title":"Cancer Cell"},{"key":"2625_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.12703\/r\/10-45","volume":"10","author":"D Valdembri","year":"2021","unstructured":"Valdembri, D. & Serini, G. The roles of integrins in cancer. Fac. Rev. 10, 45 (2021).","journal-title":"Fac. Rev."},{"key":"2625_CR13","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41568-018-0038-z","volume":"18","author":"H Hamidi","year":"2018","unstructured":"Hamidi, H. & Ivaska, J. Every step of the way: integrins in cancer progression and metastasis. Nat. Rev. Cancer 18, 533\u2013548 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"2625_CR14","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ccell.2019.01.007","volume":"35","author":"J Cooper","year":"2019","unstructured":"Cooper, J. & Giancotti, F. G. Integrin signaling in cancer: mechanotransduction, stemness, epithelial plasticity, and therapeutic resistance. Cancer Cell 35, 347\u2013367 (2019).","journal-title":"Cancer Cell"},{"key":"2625_CR15","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature15756","volume":"527","author":"A Hoshino","year":"2015","unstructured":"Hoshino, A. et al. Tumour exosome integrins determine organotropic metastasis. Nature 527, 329\u2013335 (2015).","journal-title":"Nature"},{"key":"2625_CR16","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1158\/0008-5472.CAN-21-4140","volume":"82","author":"B Hu","year":"2022","unstructured":"Hu, B. et al. Inhibition of EGFR overcomes acquired lenvatinib resistance driven by STAT3-ABCB1 signaling in hepatocellular carcinoma. Cancer Res. 82, 3845\u20133857 (2022).","journal-title":"Cancer Res."},{"key":"2625_CR17","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.cell.2016.01.043","volume":"164","author":"M Tkach","year":"2016","unstructured":"Tkach, M. & Th\u00e9ry, C. Communication by extracellular vesicles: where we are and where we need to go. Cell 164, 1226\u20131232 (2016).","journal-title":"Cell"},{"key":"2625_CR18","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1002\/hep.32662","volume":"77","author":"X Liu","year":"2023","unstructured":"Liu, X. et al. Hepatocyte-derived MASP1-enriched small extracellular vesicles activate HSCs to promote liver fibrosis. Hepatology 77, 1181\u20131197 (2023).","journal-title":"Hepatology"},{"key":"2625_CR19","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.jhep.2020.04.044","volume":"73","author":"J Gao","year":"2020","unstructured":"Gao, J. et al. Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis. J. Hepatol. 73, 1144\u20131154 (2020).","journal-title":"J. Hepatol."},{"key":"2625_CR20","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1080\/15548627.2019.1635383","volume":"16","author":"XW Zhang","year":"2020","unstructured":"Zhang, X. W. et al. Disrupting the TRIB3-SQSTM1 interaction reduces liver fibrosis by restoring autophagy and suppressing exosome-mediated HSC activation. Autophagy 16, 782\u2013796 (2020).","journal-title":"Autophagy"},{"key":"2625_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1172\/JCI73939","volume":"125","author":"YC Kim","year":"2015","unstructured":"Kim, Y. C. & Guan, K. L. mTOR: a pharmacologic target for autophagy regulation. J. Clin. Invest. 125, 25\u201332 (2015).","journal-title":"J. Clin. Invest."},{"key":"2625_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s43556-020-00022-z","volume":"2","author":"H Wang","year":"2021","unstructured":"Wang, H. et al. Characteristics of pre-metastatic niche: the landscape of molecular and cellular pathways. Mol. Biomed. 2, 3 (2021).","journal-title":"Mol. Biomed."},{"key":"2625_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.tcb.2023.06.006","volume":"34","author":"SB Arya","year":"2024","unstructured":"Arya, S. B., Collie, S. P. & Parent, C. A. The ins-and-outs of exosome biogenesis, secretion, and internalization. Trends Cell Biol. 34, 90\u2013108 (2024).","journal-title":"Trends Cell Biol."},{"key":"2625_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet, JM. et al. Hepatocellular carcinoma. Nat. Rev. Dis. Primers. 7, 6 (2021).","journal-title":"Nat. Rev. Dis. Primers."},{"key":"2625_CR25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","volume":"575","author":"N Vasan","year":"2019","unstructured":"Vasan, N., Baselga, J. & Hyman, D. M. A view on drug resistance in cancer. Nature 575, 299\u2013309 (2019).","journal-title":"Nature"},{"key":"2625_CR26","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nrclinonc.2011.83","volume":"8","author":"K De Bock","year":"2011","unstructured":"De Bock, K., Mazzone, M. & Carmeliet, P. Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not? Nat. Rev. Clin. Oncol. 8, 393\u2013404 (2011).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2625_CR27","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nrclinonc.2011.21","volume":"8","author":"JM Ebos","year":"2011","unstructured":"Ebos, J. M. & Kerbel, R. S. Antiangiogenic therapy: impact on invasion, disease progression, and metastasis. Nat. Rev. Clin. Oncol. 8, 210\u2013221 (2011).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2625_CR28","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1053\/j.gastro.2012.08.032","volume":"143","author":"W Zhang","year":"2012","unstructured":"Zhang, W. et al. Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice. Gastroenterology 143, 1641\u20131649.e1645 (2012).","journal-title":"Gastroenterology"},{"key":"2625_CR29","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.1158\/1078-0432.CCR-09-2904","volume":"16","author":"W Zhang","year":"2010","unstructured":"Zhang, W. et al. Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects. Clin. Cancer Res. 16, 3420\u20133430 (2010).","journal-title":"Clin. Cancer Res."},{"key":"2625_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13046-018-0750-2","volume":"37","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. The dual blockade of MET and VEGFR2 signaling demonstrates pronounced inhibition on tumor growth and metastasis of hepatocellular carcinoma. J. Exp. Clin. Cancer Res. 37, 93 (2018).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2625_CR31","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1053\/j.gastro.2020.05.052","volume":"159","author":"M Armacki","year":"2020","unstructured":"Armacki, M. et al. Protein kinase D1, reduced in human pancreatic tumors, increases secretion of small extracellular vesicles from cancer cells that promote metastasis to lung in mice. Gastroenterology 159, 1019\u20131035.e1022 (2020).","journal-title":"Gastroenterology"},{"key":"2625_CR32","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nrc.2017.6","volume":"17","author":"H Peinado","year":"2017","unstructured":"Peinado, H. et al. Pre-metastatic niches: organ-specific homes for metastases. Nat. Rev. Cancer 17, 302\u2013317 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"2625_CR33","doi-asserted-by":"crossref","unstructured":"Kong, J. et al. Extracellular vesicles of carcinoma-associated fibroblasts creates a pre-metastatic niche in the lung through activating fibroblasts. Mol. Cancer 18, 175 (2019).","DOI":"10.1186\/s12943-019-1101-4"},{"key":"2625_CR34","doi-asserted-by":"crossref","unstructured":"GongZ. et al. Lung fibroblasts support metastasis through immune microenvironment remodeling. Cancer Discov. 12, Of10 (2022).","DOI":"10.1158\/2159-8290.CD-RW2022-149"},{"key":"2625_CR35","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.immuni.2022.07.001","volume":"55","author":"Z Gong","year":"2022","unstructured":"Gong, Z. et al. Lung fibroblasts facilitate pre-metastatic niche formation by remodeling the local immune microenvironment. Immunity 55, 1483\u20131500.e1489 (2022).","journal-title":"Immunity"},{"key":"2625_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02583-0","volume":"9","author":"T Fang","year":"2018","unstructured":"Fang, T. et al. Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer. Nat. Commun. 9, 191 (2018).","journal-title":"Nat. Commun."},{"key":"2625_CR37","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.semcdb.2017.08.022","volume":"74","author":"T Juan","year":"2018","unstructured":"Juan, T. & F\u00fcrthauer, M. Biogenesis and function of ESCRT-dependent extracellular vesicles. Semin. Cell Dev. Biol. 74, 66\u201377 (2018).","journal-title":"Semin. Cell Dev. Biol."},{"key":"2625_CR38","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.3390\/ijms21072576","volume":"21","author":"S Buratta","year":"2020","unstructured":"Buratta, S. et al. Lysosomal exocytosis, exosome release and secretory autophagy: the autophagic- and endo-lysosomal systems go extracellular. Int. J. Mol. Sci. 21, 2576 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"2625_CR39","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1002\/hep.30766","volume":"70","author":"M Babuta","year":"2019","unstructured":"Babuta, M. et al. Dysregulated autophagy and lysosome function are linked to exosome production by micro-RNA 155 in alcoholic liver disease. Hepatology 70, 2123\u20132141 (2019).","journal-title":"Hepatology"},{"key":"2625_CR40","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3389\/fimmu.2014.00403","volume":"5","author":"F Baixauli","year":"2014","unstructured":"Baixauli, F., L\u00f3pez-Ot\u00edn, C. & Mittelbrunn, M. Exosomes and autophagy: coordinated mechanisms for the maintenance of cellular fitness. Front. Immunol. 5, 403 (2014).","journal-title":"Front. Immunol."},{"key":"2625_CR41","doi-asserted-by":"publisher","first-page":"1801313","DOI":"10.1002\/advs.201801313","volume":"6","author":"W Zou","year":"2019","unstructured":"Zou, W. et al. Exosome release is regulated by mTORC1. Adv. Sci. 6, 1801313 (2019).","journal-title":"Adv. Sci."},{"key":"2625_CR42","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1158\/0008-5472.CAN-19-1145","volume":"80","author":"S Ruan","year":"2020","unstructured":"Ruan, S. et al. Integrin \u03b24-targeted cancer immunotherapies inhibit tumor growth and decrease metastasis. Cancer Res. 80, 771\u2013783 (2020).","journal-title":"Cancer Res."},{"key":"2625_CR43","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.trecan.2016.10.006","volume":"2","author":"Y Guri","year":"2016","unstructured":"Guri, Y. & Hall, M. N. mTOR signaling confers resistance to targeted cancer drugs. Trends Cancer 2, 688\u2013697 (2016).","journal-title":"Trends Cancer"},{"key":"2625_CR44","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.trecan.2016.03.008","volume":"2","author":"E Ilagan","year":"2016","unstructured":"Ilagan, E. & Manning, B. D. Emerging role of mTOR in the response to cancer therapeutics. Trends Cancer 2, 241\u2013251 (2016).","journal-title":"Trends Cancer"},{"key":"2625_CR45","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cmet.2014.01.001","volume":"19","author":"J Li","year":"2014","unstructured":"Li, J., Kim, S. G. & Blenis, J. Rapamycin: one drug, many effects. Cell Metab. 19, 373\u2013379 (2014).","journal-title":"Cell Metab."},{"key":"2625_CR46","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nrd3531","volume":"10","author":"D Benjamin","year":"2011","unstructured":"Benjamin, D., Colombi, M., Moroni, C. & Hall, M. N. Rapamycin passes the torch: a new generation of mTOR inhibitors. Nat. Rev. Drug Discov. 10, 868\u2013880 (2011).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2625_CR47","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg3358","volume":"15","author":"S Ji","year":"2023","unstructured":"Ji, S. et al. Pharmaco-proteogenomic characterization of liver cancer organoids for precision oncology. Sci. Transl. Med. 15, eadg3358 (2023).","journal-title":"Sci. Transl. Med."},{"key":"2625_CR48","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1136\/gutjnl-2020-320716","volume":"70","author":"R Shang","year":"2021","unstructured":"Shang, R. et al. Cabozantinib-based combination therapy for the treatment of hepatocellular carcinoma. Gut 70, 1746\u20131757 (2021).","journal-title":"Gut"},{"key":"2625_CR49","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.2215\/CJN.15040920","volume":"16","author":"D Wojciechowski","year":"2021","unstructured":"Wojciechowski, D. & Wiseman, A. Long-term immunosuppression management: opportunities and uncertainties. Clin. J. Am. Soc. Nephrol. 16, 1264\u20131271 (2021).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"2625_CR50","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1055\/s-0030-1247132","volume":"30","author":"R Lencioni","year":"2010","unstructured":"Lencioni, R. & Llovet, J. M. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin. Liver Dis. 30, 52\u201360 (2010).","journal-title":"Semin. Liver Dis."},{"key":"2625_CR51","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jhep.2019.09.026","volume":"72","author":"JM Llovet","year":"2020","unstructured":"Llovet, J. M. & Lencioni, R. mRECIST for HCC: performance and novel refinements. J. Hepatol. 72, 288\u2013306 (2020).","journal-title":"J. Hepatol."},{"key":"2625_CR52","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13045-020-00987-y","volume":"13","author":"L Zhu","year":"2020","unstructured":"Zhu, L. et al. Isolation and characterization of exosomes for cancer research. J. Hematol. Oncol. 13, 152 (2020).","journal-title":"J. Hematol. Oncol."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02625-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02625-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02625-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T12:02:46Z","timestamp":1776340966000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02625-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2625"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02625-4","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"17 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"138"}}